课题基金 / 基金详情

Training Grant in Transfusion Medicine

Training Grant in Transfusion Medicine
输血医学培训补助金
批准号:
10390476
负责人:
John D Roback
金额:
$17.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
未结题
起止时间:
2004-04-01 至 2025-03-31

项目摘要

项目成果

John D Roback的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a renewal NRSA application (T32 HL69769, “Training grant in transfusion medicine”) requesting continued support to maintain an effective and productive Transfusion Medicine Research Training Fellowship at Emory University. Research in transfusion medicine is vital to the future of the field and, downstream, to the safety of recipients of transfusion and cellular therapies worldwide. The Emory Center for Transfusion and Cellular Therapies (CTCT) is one of the largest, most comprehensive academic transfusion medicine programs in the nation and is dedicated to excellence in clinical service, outstanding basic, translational and clinical research, and the clinical and research-based training of future leaders in the field. This T32 Post-Doctoral Scientist Training Program is a critical element in both contributing to, and fulfilling the mission of, the Emory CTCT. If funding is renewed, this grant would continue to provide salary support for two post-doctoral CTCT Research Trainees per year for a 5-year period to participate in a highly structured, mentored training program in transfusion medicine research. We aim to fill the acknowledged need for basic, translational, and interdisciplinary research training in transfusion medicine. Such training is needed to develop future specialists in transfusion, cell therapy and transplantation research in order to contribute to the further growth and research development of the specialty and its ability to contribute to other fields of research and clinical practice. Program strengths previously identified include: the Principal Investigator/Program Director; the organization of the training plan as a small-scale program emphasizing high-quality candidates and research projects; the involvement of senior faculty with strong scientific, funding, and training records; the provision of specific mechanisms for educating fellows and externally evaluating the training program; and the academic successes of previously-supported Fellows. To further underscore the program’s commitment to providing direct personal effort in training post-doctoral research fellows, the faculty mentors have been limited to only those with significant funding and proven track records in training early-career investigators. The Program was initially funded in 2004, and renewed in 2009 and 2014. We are now applying for a third renewal to commence in 2019. To date, 14 Fellows have completed the program, two Fellows are in the middle of training, and two candidates have been identified to begin their fellowships mid/late-2019 should funding be renewed. Our T32 Fellows have been highly successful as evidenced by manuscript publications, faculty appointments, grant support, and Steering Committee review. The Program Director greatly appreciates the funding that has been provided to support this important training effort, and the time and effort volunteered by the reviewers in evaluating this Fellowship.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Sample Procurement and Clinical Core
  • 批准号:
    10222318
  • 项目类别:
  • 资助金额:
    $53.03万
  • 财政年份:
    2020
  • 负责人:
    John D Roback
  • 依托单位:
Core 1: Sample Procurement and Clinical Core
  • 批准号:
    10680629
  • 项目类别:
  • 资助金额:
    $22.61万
  • 财政年份:
    2020
  • 负责人:
    John D Roback
  • 依托单位:
Microfluidic Technologies as Clinical Biomarker Platforms for Sickle Cell Gene Therapies
  • 批准号:
    10001892
  • 项目类别:
  • 资助金额:
    $3.2万
  • 财政年份:
    2019
  • 负责人:
    John D Roback
  • 依托单位:
Engineering iPSC-RBCs for Transfusion
  • 批准号:
    9385217
  • 项目类别:
  • 资助金额:
    $60.57万
  • 财政年份:
    2017
  • 负责人:
    John D Roback
  • 依托单位:
海外基金